KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Bionano Genomics (BNGO) Debt Ratio (2017 - 2023)

Bionano Genomics (BNGO) has disclosed Debt Ratio for 7 consecutive years, with 0.05 as the latest value for Q3 2023.

  • Quarterly Debt Ratio rose 91.28% to 0.05 in Q3 2023 from the year-ago period, while the trailing twelve-month figure was 0.05 through Sep 2023, up 91.28% year-over-year, with the annual reading at 0.03 for FY2022, N/A changed from the prior year.
  • Debt Ratio hit 0.05 in Q3 2023 for Bionano Genomics, up from 0.04 in the prior quarter.
  • In the past five years, Debt Ratio ranged from a high of 1.03 in Q3 2019 to a low of 0.03 in Q2 2022.
  • Historically, Debt Ratio has averaged 0.36 across 5 years, with a median of 0.27 in 2020.
  • Biggest five-year swings in Debt Ratio: soared 249.73% in 2019 and later plummeted 95.65% in 2021.
  • Year by year, Debt Ratio stood at 0.66 in 2019, then tumbled by 59.38% to 0.27 in 2020, then plummeted by 85.7% to 0.04 in 2021, then decreased by 21.01% to 0.03 in 2022, then skyrocketed by 80.18% to 0.05 in 2023.
  • Business Quant data shows Debt Ratio for BNGO at 0.05 in Q3 2023, 0.04 in Q2 2023, and 0.03 in Q1 2023.